NCT02298595 Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma Status WITHDRAWN Phase PHASE1/PHASE2
NCT02223975 Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease Status SUSPENDED Phase N/A
NCT02213133 Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas Status TERMINATED Phase PHASE2
NCT02151149 Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly Status COMPLETED Phase PHASE4
NCT02133196 T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT02131805 Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma Status COMPLETED Phase NA
NCT02128906 Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design Status RECRUITING Phase PHASE2
NCT02095912 Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients Status COMPLETED Phase N/A
NCT02088515 Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma Status COMPLETED Phase PHASE4
NCT02059252 Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold Status TERMINATED Phase PHASE1/PHASE2
NCT02013154 A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab Status COMPLETED Phase PHASE1
NCT01976468 Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study" Status UNKNOWN Phase N/A
NCT01905891 Nanocytology Test to Evaluate Skin Cancer in High Risk Patients Status COMPLETED Phase NA
NCT01872130 Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins Status COMPLETED Phase N/A
NCT01794845 Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma Status TERMINATED Phase PHASE2
NCT01770002 Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved? Status COMPLETED Phase NA
NCT01760811 CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT Status UNKNOWN Phase PHASE1/PHASE2
NCT01755650 Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies Status TERMINATED Phase EARLY_PHASE1
NCT01666431 Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment Status TERMINATED Phase PHASE2